Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Respiratory Medicine Case Reports
|
December 3, 2019
Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma
Angus G Dalgleish, Emma McLean, Nirav Patel, et al.
Science (New York, N.Y.)
|
July 29, 2006
Origins of HIV and the evolution of resistance to AIDS
Jonathan L Heeney, Angus G Dalgleish, Robin A Weiss
Current Clinical Pharmacology
|
October 8, 2010
Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids
Wai M Liu, Daniel W Fowler, Angus G Dalgleish
Molecular Cancer Therapeutics
|
November 16, 2014
The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model
Katherine A Scott, Angus G Dalgleish, Wai M Liu
International Journal of Cancer
|
October 2, 2010
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies
Wai M Liu, Andrew M Gravett, Angus G Dalgleish
International Journal of Cancer
|
November 30, 2006
Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells
Petros X E Mouratidis, Kay W Colston, Angus G Dalgleish
Pancreas
|
December 13, 2005
Investigation of the mechanisms by which EB1089 abrogates apoptosis induced by 9-cis retinoic acid in pancreatic cancer cells
Petros X E Mouratidis, Angus G Dalgleish, Kay W Colston
Anticancer Research
|
November 24, 2011
Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide
Rosemary A Fryer, Blake Barlett, Christine Galustian, et al.
AIDS Research and Human Retroviruses
|
June 12, 2008
HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120
Martin Cadogan, Brian Austen, Jonathan L Heeney, et al.
Cancer Immunology, Immunotherapy : CII
|
October 18, 2002
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy
Keith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Respiratory Medicine Case Reports
|
December 3, 2019
Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma
Angus G Dalgleish, Emma McLean, Nirav Patel, et al.
Science (New York, N.Y.)
|
July 29, 2006
Origins of HIV and the evolution of resistance to AIDS
Jonathan L Heeney, Angus G Dalgleish, Robin A Weiss
Current Clinical Pharmacology
|
October 8, 2010
Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids
Wai M Liu, Daniel W Fowler, Angus G Dalgleish
Molecular Cancer Therapeutics
|
November 16, 2014
The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model
Katherine A Scott, Angus G Dalgleish, Wai M Liu
International Journal of Cancer
|
October 2, 2010
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies
Wai M Liu, Andrew M Gravett, Angus G Dalgleish
International Journal of Cancer
|
November 30, 2006
Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells
Petros X E Mouratidis, Kay W Colston, Angus G Dalgleish
Pancreas
|
December 13, 2005
Investigation of the mechanisms by which EB1089 abrogates apoptosis induced by 9-cis retinoic acid in pancreatic cancer cells
Petros X E Mouratidis, Angus G Dalgleish, Kay W Colston
Anticancer Research
|
November 24, 2011
Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide
Rosemary A Fryer, Blake Barlett, Christine Galustian, et al.
AIDS Research and Human Retroviruses
|
June 12, 2008
HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120
Martin Cadogan, Brian Austen, Jonathan L Heeney, et al.
Cancer Immunology, Immunotherapy : CII
|
October 18, 2002
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy
Keith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Page
of 9